Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-112,100
Closed -$12.7M 3014
2024
Q3
$12.7M Sell
112,100
-9,800
-8% -$1.16M 0.03% 409
2024
Q2
$15.1M Sell
121,900
-67,500
-36% -$8.69M 0.03% 334
2024
Q1
$25M Buy
189,400
+5,300
+3% +$653K 0.05% 210
2023
Q4
$20.1M Sell
184,100
-17,000
-8% -$1.76M 0.03% 338
2023
Q3
$20.7M Buy
+201,100
New +$21.7M 0.04% 323

Other funds holding MRK

GTS Securities's MRK Position: Q1 2026 in Review

GTS Securities reduced its Merck (MRK) stake by 72% in Q1 2026, selling an estimated $2.75M and leaving 9,305 shares worth $1.12M. The position accounts for 0.04% of the portfolio, ranked #352.

GTS Securities first reported a position in MRK in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.61M in Q4 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • GTS Securities held 9,305 shares of Merck worth $1.12M as of Q1 2026.
  • GTS Securities sold 23,789 Merck shares in Q1 2026, an estimated $2.75M.
  • Merck made up 0.04% of GTS Securities's portfolio in Q1 2026, its #352 holding.
  • GTS Securities first reported a position in Merck in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Merck position peaked at $4.61M in Q4 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.